Related Stories
New study questions value of mammograms for breast cancer screening
Key Excerpts from Article on Website of CBS News/Associated Press
Posted: October 23rd, 2016
http://www.cbsnews.com/news/new-study-questions-value-of-mam...
A new study questions the value of mammograms for breast cancer screening. It concludes that a woman is more likely to be diagnosed with a small tumor that is not destined to grow than she is to have a true problem spotted early. The work could further shift the balance of whether screenings harms outweigh its benefits. Screening is only worthwhile if it finds cancers that would kill, and if treating them early improves survival versus treating when or if they ever cause symptoms. Treatment has improved so much over the years that detecting cancer early has become less important. Mammograms do catch some deadly cancers and save lives. But they also find many early cancers that are not destined to grow or spread and become a health threat. There is no good way to tell which ones will, so many women get treatments they dont really need. Its a twin problem: overdiagnosis and overtreatment. Women were considerably more likely to have tumors that were overdiagnosed than to have earlier detection of a tumor that was destined to become large, the authors write. Dr. Joann Elmore of the University of Washington School of Medicine in Seattle, writes in a commentary in the journal that its time to pay more attention to the collateral damage of screening - overdiagnosis. The mantras, All cancers are life-threatening and When in doubt, cut it out, require revision, she wrote.
Note: A previous study by The U.S. Preventive Services Task Force, federal advisory panel, found that annual mammograms greatly increase false-positive cancer diagnoses, leading to unnecessary treatment. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.